Hideki Maeda
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
Important missing information in Japan's risk management plans: a cross-sectional analysis after a decade of implementation.
Journal: Frontiers in medicine
Published: May 30, 2026
Correction: Current situation and issues regarding termination of risk management plans in Japan.
Journal: Frontiers in medicine
Published: May 24, 2026
A landscape analysis of Japanese tolerability assessments in oncology drug development.
Journal: Cancer treatment and research communications
Published: April 03, 2026
Identifying Factors Associated with the Acquisition of Multiple Indications for Anticancer Drugs.
Journal: Current oncology (Toronto, Ont.)
Published: March 30, 2026
Tumor-Specific Success Probabilities and Factors Associated With Phase III Trials in Oncology Drug Development.
Journal: Clinical and translational science
Published: February 23, 2026
Post-Marketing Requirements for Anticancer Drugs Approved in Japan, 2001-2024: A Cross-Sectional Analysis.
Journal: CPT: pharmacometrics & systems pharmacology
Published: December 26, 2025
Electronic Patient-Reported Outcomes With Vital Sign Monitoring During Trastuzumab Deruxtecan Therapy: The PRO-DUCE Randomized Clinical Trial.
Journal: JAMA network open
Published: August 15, 2025
Adverse Event Reports and Safety Measures for Breast Implant-associated Anaplastic Large Cell Lymphoma in Japan.
Journal: Plastic and reconstructive surgery. Global open
Published: August 02, 2025
Case Report: Overcoming calcified nodules by repeated aggressive debulking and stent-free percunatenous coronary intervention using a drug-coated balloon.
Journal: Frontiers in cardiovascular medicine
Published: July 28, 2025
Interactions Between Pharmaceutical Companies and Patient Advocacy Groups in Japan: A Qualitative and Quantitative Interview Study.
Journal: Risk management and healthcare policy
Published: July 15, 2025
Prognostic value of HER2 discordance between primary and metastatic or recurrent breast cancer: A systematic review and meta-analysis.
Journal: Critical reviews in oncology/hematology
Published: July 15, 2025
Last Updated: 09/26/2026